title: Phaeochromocytoma in various disguises.
abstract: Patients with phaeochromocytoma may present a broad spectrum of clinical manifestations as presented here in 5 case reports. Pathophysiology, clinical management, pharmacotherapy and associated diseases are discussed. Although catecholamine measurements in both urine and blood as well as modern localisation techniques are valuable adjuncts to establishing the diagnosis, a high index of suspicion remains the key to this diagnosis.
authors.affiliation: Department of Internal Medicine, University Hospital, Groningen, Netherlands.
authors.forename: J F
authors.initials: JF
authors.lastname: Monkelbaan
authors.forename: H A
authors.initials: HA
authors.lastname: Cats
authors.forename: C H
authors.initials: CH
authors.lastname: Beerenhout
authors.forename: R P
authors.initials: RP
authors.lastname: Dullaart
authors.forename: T W
authors.initials: TW
authors.lastname: van Haeften
mesh_terms: D000310:Adrenal Gland Neoplasms / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002395:Catecholamines / Q000378:metabolism; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000209:etiology; D008297:Male; D008875:Middle Aged; D010643:Phenoxybenzamine / Q000627:therapeutic use; D010673:Pheochromocytoma / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000175:diagnosis
chemical_list: D000959:Antihypertensive Agents; D002395:Catecholamines; D010643:Phenoxybenzamine